BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30159728)

  • 41. Factors predicting patient perception of dysphonia caused by benign vocal fold lesions.
    Behrman A; Sulica L; He T
    Laryngoscope; 2004 Oct; 114(10):1693-700. PubMed ID: 15454756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and efficacy of carboxymethylcellulose in the treatment of glottic insufficiency.
    Mallur PS; Morrison MP; Postma GN; Amin MR; Rosen CA
    Laryngoscope; 2012 Feb; 122(2):322-6. PubMed ID: 22258817
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative analysis on the efficiency of the injection laryngoplasty technique using calcium hydroxyapatite (CaHA): the thyrohyoid approach versus the cricothyroid approach.
    Woo SH; Son YI; Lee SH; Park JJ; Kim JP
    J Voice; 2013 Mar; 27(2):236-41. PubMed ID: 23280385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A prospective crossover trial of botulinum toxin chemodenervation versus injection augmentation for essential voice tremor.
    Estes C; Sadoughi B; Coleman R; Sarva H; Mauer E; Sulica L
    Laryngoscope; 2018 Feb; 128(2):437-446. PubMed ID: 28988441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prospective multi-arm evaluation of surgical treatments for vocal fold scar and pathologic sulcus vocalis.
    Welham NV; Choi SH; Dailey SH; Ford CN; Jiang JJ; Bless DM
    Laryngoscope; 2011 Jun; 121(6):1252-60. PubMed ID: 21557241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of sulcus vocalis: auditory perceptual and acoustical analysis of the slicing mucosa surgical technique.
    Pontes P; Behlau M
    J Voice; 1993 Dec; 7(4):365-76. PubMed ID: 8293069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcome of regenerative therapy for age-related vocal fold atrophy with basic fibroblast growth factor.
    Ohno S; Hirano S; Yasumoto A; Ikeda H; Takebayashi S; Miura M
    Laryngoscope; 2016 Aug; 126(8):1844-8. PubMed ID: 27075110
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prospective study of voice outcomes and patient tolerance of in-office percutaneous injection laryngoplasty.
    Birkent H; Sardesai M; Hu A; Merati AL
    Laryngoscope; 2013 Jul; 123(7):1759-62. PubMed ID: 23606269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of long-term voice outcomes after vocal fold augmentation using autologous fat injection by direct microlaryngoscopy versus office-based calcium hydroxylapatite injection.
    Zeleník K; Walderová R; Kučová H; Jančatová D; Komínek P
    Eur Arch Otorhinolaryngol; 2017 Aug; 274(8):3147-3151. PubMed ID: 28478500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Combined autologous fascia transplantation with autologous fascia and fat injection into the vocal fold for sulcus vocalis].
    Zhang HY; Ren Y; Xu W
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Oct; 56(10):1080-1086. PubMed ID: 34666469
    [No Abstract]   [Full Text] [Related]  

  • 51. Office-based Autologous Fat Injection Laryngoplasty for Vocal Process Granuloma.
    Hu HC; Hung YT; Lin SY; Chang SY
    J Voice; 2016 Nov; 30(6):758.e7-758.e11. PubMed ID: 26454769
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Temporalis fascia transplant for vocal fold scar and sulcus vocalis.
    Pitman MJ; Rubino SM; Cooper AL
    Laryngoscope; 2014 Jul; 124(7):1653-8. PubMed ID: 24281875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Voice outcomes of polyacrylamide hydrogel injection laryngoplasty.
    Lee SW; Son YI; Kim CH; Lee JY; Kim SC; Koh YW
    Laryngoscope; 2007 Oct; 117(10):1871-5. PubMed ID: 17690620
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quality of the voice after injection of hyaluronic acid into the vocal fold.
    Szkiełkowska A; Miaśkiewicz B; Remacle M; Krasnodębska P; Skarżyński H
    Med Sci Monit; 2013 Apr; 19():276-82. PubMed ID: 23591165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medialization laryngoplasty with strap muscle transposition for vocal fold atrophy with or without sulcus vocalis.
    Su CY; Tsai SS; Chiu JF; Cheng CA
    Laryngoscope; 2004 Jun; 114(6):1106-12. PubMed ID: 15179222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment outcomes of injection laryngoplasty using cross-linked porcine collagen and hyaluronic acid.
    Wen MH; Cheng PW; Liao LJ; Chou HW; Wang CT
    Otolaryngol Head Neck Surg; 2013 Dec; 149(6):900-6. PubMed ID: 24128900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Implantation of an atelocollagen sheet for the treatment of vocal fold scarring and sulcus vocalis.
    Kishimoto Y; Hirano S; Kojima T; Kanemaru S; Ito J
    Ann Otol Rhinol Laryngol; 2009 Sep; 118(9):613-20. PubMed ID: 19810599
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medialization laryngoplasty for odynophonia.
    Kupfer RA; Merati AL; Sulica L
    JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):556-61. PubMed ID: 25812158
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term results of Artecoll injection laryngoplasty for patients with unilateral vocal fold motion impairment: safety and clinical efficacy.
    Min JY; Hong SD; Kim K; Son YI
    Arch Otolaryngol Head Neck Surg; 2008 May; 134(5):490-6. PubMed ID: 18490569
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.